世界のランレオチド薬市場予測2023-2029：60mg、90mg、120mg

【英語タイトル】Lanreotide Drugs Market, Global Outlook and Forecast 2023-2029

・商品コード：MMG23LY8539
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：79
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のランレオチド薬市場規模と予測を収録しています。・世界のランレオチド薬市場：売上、2018年-2023年、2024年-2029年
・世界のランレオチド薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のランレオチド薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「60mg」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ランレオチド薬のグローバル主要企業は、IPSENなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ランレオチド薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のランレオチド薬市場：タイプ別、2018年-2023年、2024年-2029年
世界のランレオチド薬市場：タイプ別市場シェア、2022年
・60mg、90mg、120mg

世界のランレオチド薬市場：用途別、2018年-2023年、2024年-2029年
世界のランレオチド薬市場：用途別市場シェア、2022年
・病院、薬局

世界のランレオチド薬市場：地域・国別、2018年-2023年、2024年-2029年
世界のランレオチド薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるランレオチド薬のグローバル売上、2018年-2023年
・主要企業におけるランレオチド薬のグローバル売上シェア、2022年
・主要企業におけるランレオチド薬のグローバル販売量、2018年-2023年
・主要企業におけるランレオチド薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
IPSEN

*************************************************************

・調査・分析レポートの概要
ランレオチド薬市場の定義
市場セグメント
世界のランレオチド薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のランレオチド薬市場規模
世界のランレオチド薬市場規模：2022年 VS 2029年
世界のランレオチド薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのランレオチド薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のランレオチド薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：60mg、90mg、120mg
ランレオチド薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局
ランレオチド薬の用途別グローバル売上・予測

・地域別市場分析
地域別ランレオチド薬市場規模 2022年と2029年
地域別ランレオチド薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
IPSEN
...

Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome
This report aims to provide a comprehensive presentation of the global market for Lanreotide Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lanreotide Drugs. This report contains market size and forecasts of Lanreotide Drugs in global, including the following market information:
Global Lanreotide Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Lanreotide Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Lanreotide Drugs companies in 2022 (%)
The global Lanreotide Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
60 mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Lanreotide Drugs include IPSEN. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lanreotide Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lanreotide Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Lanreotide Drugs Market Segment Percentages, by Type, 2022 (%)
60 mg
90 mg
120 mg
Global Lanreotide Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Lanreotide Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Lanreotide Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Lanreotide Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lanreotide Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Lanreotide Drugs revenues share in global market, 2022 (%)
Key companies Lanreotide Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Lanreotide Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
IPSEN
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lanreotide Drugs, market overview.
Chapter 2: Global Lanreotide Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Lanreotide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lanreotide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Lanreotide Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Lanreotide Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lanreotide Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lanreotide Drugs Overall Market Size
2.1 Global Lanreotide Drugs Market Size: 2022 VS 2029
2.2 Global Lanreotide Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Lanreotide Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Lanreotide Drugs Players in Global Market
3.2 Top Global Lanreotide Drugs Companies Ranked by Revenue
3.3 Global Lanreotide Drugs Revenue by Companies
3.4 Global Lanreotide Drugs Sales by Companies
3.5 Global Lanreotide Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Lanreotide Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Lanreotide Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lanreotide Drugs Players in Global Market
3.8.1 List of Global Tier 1 Lanreotide Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Lanreotide Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Lanreotide Drugs Market Size Markets, 2022 & 2029
4.1.2 60 mg
4.1.3 90 mg
4.1.4 120 mg
4.2 By Type – Global Lanreotide Drugs Revenue & Forecasts
4.2.1 By Type – Global Lanreotide Drugs Revenue, 2018-2023
4.2.2 By Type – Global Lanreotide Drugs Revenue, 2024-2029
4.2.3 By Type – Global Lanreotide Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Lanreotide Drugs Sales & Forecasts
4.3.1 By Type – Global Lanreotide Drugs Sales, 2018-2023
4.3.2 By Type – Global Lanreotide Drugs Sales, 2024-2029
4.3.3 By Type – Global Lanreotide Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Lanreotide Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Lanreotide Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Lanreotide Drugs Revenue & Forecasts
5.2.1 By Application – Global Lanreotide Drugs Revenue, 2018-2023
5.2.2 By Application – Global Lanreotide Drugs Revenue, 2024-2029
5.2.3 By Application – Global Lanreotide Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Lanreotide Drugs Sales & Forecasts
5.3.1 By Application – Global Lanreotide Drugs Sales, 2018-2023
5.3.2 By Application – Global Lanreotide Drugs Sales, 2024-2029
5.3.3 By Application – Global Lanreotide Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Lanreotide Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Lanreotide Drugs Market Size, 2022 & 2029
6.2 By Region – Global Lanreotide Drugs Revenue & Forecasts
6.2.1 By Region – Global Lanreotide Drugs Revenue, 2018-2023
6.2.2 By Region – Global Lanreotide Drugs Revenue, 2024-2029
6.2.3 By Region – Global Lanreotide Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Lanreotide Drugs Sales & Forecasts
6.3.1 By Region – Global Lanreotide Drugs Sales, 2018-2023
6.3.2 By Region – Global Lanreotide Drugs Sales, 2024-2029
6.3.3 By Region – Global Lanreotide Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Lanreotide Drugs Revenue, 2018-2029
6.4.2 By Country – North America Lanreotide Drugs Sales, 2018-2029
6.4.3 US Lanreotide Drugs Market Size, 2018-2029
6.4.4 Canada Lanreotide Drugs Market Size, 2018-2029
6.4.5 Mexico Lanreotide Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Lanreotide Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Lanreotide Drugs Sales, 2018-2029
6.5.3 Germany Lanreotide Drugs Market Size, 2018-2029
6.5.4 France Lanreotide Drugs Market Size, 2018-2029
6.5.5 U.K. Lanreotide Drugs Market Size, 2018-2029
6.5.6 Italy Lanreotide Drugs Market Size, 2018-2029
6.5.7 Russia Lanreotide Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Lanreotide Drugs Market Size, 2018-2029
6.5.9 Benelux Lanreotide Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Lanreotide Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Lanreotide Drugs Sales, 2018-2029
6.6.3 China Lanreotide Drugs Market Size, 2018-2029
6.6.4 Japan Lanreotide Drugs Market Size, 2018-2029
6.6.5 South Korea Lanreotide Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Lanreotide Drugs Market Size, 2018-2029
6.6.7 India Lanreotide Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Lanreotide Drugs Revenue, 2018-2029
6.7.2 By Country – South America Lanreotide Drugs Sales, 2018-2029
6.7.3 Brazil Lanreotide Drugs Market Size, 2018-2029
6.7.4 Argentina Lanreotide Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Lanreotide Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Lanreotide Drugs Sales, 2018-2029
6.8.3 Turkey Lanreotide Drugs Market Size, 2018-2029
6.8.4 Israel Lanreotide Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Lanreotide Drugs Market Size, 2018-2029
6.8.6 UAE Lanreotide Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 IPSEN
7.1.1 IPSEN Company Summary
7.1.2 IPSEN Business Overview
7.1.3 IPSEN Lanreotide Drugs Major Product Offerings
7.1.4 IPSEN Lanreotide Drugs Sales and Revenue in Global (2018-2023)
7.1.5 IPSEN Key News & Latest Developments
8 Global Lanreotide Drugs Production Capacity, Analysis
8.1 Global Lanreotide Drugs Production Capacity, 2018-2029
8.2 Lanreotide Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Lanreotide Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Lanreotide Drugs Supply Chain Analysis
10.1 Lanreotide Drugs Industry Value Chain
10.2 Lanreotide Drugs Upstream Market
10.3 Lanreotide Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lanreotide Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Lanreotide Drugs in Global Market
Table 2. Top Lanreotide Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Lanreotide Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Lanreotide Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Lanreotide Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Lanreotide Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Lanreotide Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Lanreotide Drugs Product Type
Table 9. List of Global Tier 1 Lanreotide Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lanreotide Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Lanreotide Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Lanreotide Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Lanreotide Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Lanreotide Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Lanreotide Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Lanreotide Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Lanreotide Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Lanreotide Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Lanreotide Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Lanreotide Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Lanreotide Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Lanreotide Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Lanreotide Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Lanreotide Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Lanreotide Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Lanreotide Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Lanreotide Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Lanreotide Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Lanreotide Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Lanreotide Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Lanreotide Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Lanreotide Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Lanreotide Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Lanreotide Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Lanreotide Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Lanreotide Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Lanreotide Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Lanreotide Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Lanreotide Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Lanreotide Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Lanreotide Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Lanreotide Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Lanreotide Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Lanreotide Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Lanreotide Drugs Sales, (K Units), 2024-2029
Table 46. IPSEN Company Summary
Table 47. IPSEN Lanreotide Drugs Product Offerings
Table 48. IPSEN Lanreotide Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. IPSEN Key News & Latest Developments
Table 50. Lanreotide Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Lanreotide Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Lanreotide Drugs Production by Region, 2018-2023 (K Units)
Table 53. Global Lanreotide Drugs Production by Region, 2024-2029 (K Units)
Table 54. Lanreotide Drugs Market Opportunities & Trends in Global Market
Table 55. Lanreotide Drugs Market Drivers in Global Market
Table 56. Lanreotide Drugs Market Restraints in Global Market
Table 57. Lanreotide Drugs Raw Materials
Table 58. Lanreotide Drugs Raw Materials Suppliers in Global Market
Table 59. Typical Lanreotide Drugs Downstream
Table 60. Lanreotide Drugs Downstream Clients in Global Market
Table 61. Lanreotide Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Lanreotide Drugs Segment by Type in 2022
Figure 2. Lanreotide Drugs Segment by Application in 2022
Figure 3. Global Lanreotide Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Lanreotide Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Lanreotide Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Lanreotide Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Lanreotide Drugs Revenue in 2022
Figure 9. By Type - Global Lanreotide Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Lanreotide Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Lanreotide Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Lanreotide Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Lanreotide Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Lanreotide Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Lanreotide Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Lanreotide Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Lanreotide Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Lanreotide Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Lanreotide Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Lanreotide Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Lanreotide Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Lanreotide Drugs Sales Market Share, 2018-2029
Figure 23. US Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Lanreotide Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Lanreotide Drugs Sales Market Share, 2018-2029
Figure 28. Germany Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Lanreotide Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Lanreotide Drugs Sales Market Share, 2018-2029
Figure 37. China Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Lanreotide Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Lanreotide Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Lanreotide Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Lanreotide Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Lanreotide Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Lanreotide Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Lanreotide Drugs by Region, 2022 VS 2029
Figure 54. Lanreotide Drugs Industry Value Chain
Figure 55. Marketing Channels

★調査レポート[世界のランレオチド薬市場予測2023-2029：60mg、90mg、120mg] (コード：MMG23LY8539)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界のランレオチド薬市場予測2023-2029：60mg、90mg、120mg]についてメールでお問い合わせ

MarketReport.jp

世界のランレオチド薬市場予測2023-2029：60mg、90mg、120mg

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp